United States

Healthcare Headlines

EU mergers and takeovers (Jan 18)

BRUSSELS, Jan 18 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Two settle U.S. charges on failing to file stock buys with regulator

WASHINGTON, Jan 17 Danaher Corp co-founder Mitchell Rales agreed to pay $720,000 to settle allegations that he failed to report stock purchases to the government so that they could be vetted to determine if they violate antitrust law, antitrust enforcers said on Tuesday.

Allergan to pay $15 mln over failing to disclose merger talks

WASHINGTON, Jan 17 Botox maker Allergan plc will pay a $15 million penalty and admit to wrongdoing, after U.S. regulators on Tuesday accused the company of failing to disclose merger talks with Actavis, the U.S. Securities and Exchange Commission said.

Bayer, Monsanto pledge U.S. R&D spending, jobs after merger

FRANKFURT, Jan 17 A future combined Bayer and Monsanto expects to spend about $16 billion on research and development over the next six years with at least half of this investment made in the United States, the two companies said in a statement on Tuesday.

« Previous Page Next Page »

Trump U.N. pick echoes his criticism but breaks from him on issues

WASHINGTON Donald Trump's pick for U.N. ambassador echoed his condemnation of the world body and pledged to push for reforms at her confirmation hearing on Wednesday, but broke from the president-elect on some other policy issues, including Russia and NATO. | Video